Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
Yahoo2d
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said. Eli Lilly's tirzepatide, sold as Zepbound for weight loss and ...
Investors Chronicle3d
This weight-loss superstar more than justifies its hefty price
Some fear weight-loss stocks are approaching bubble territory, but this incumbent player continues to prove its worth ...
12 Best Growth Stocks to Buy According to Hedge Funds
In this article, we will discuss: 12 Best Growth Stocks To Buy According To Hedge Funds.
Fed Rate Cuts Are Less Urgent After Powell Made Breathing Space. Here’s Why and 5 Other Things to Know Today.
OpenAI nearly doubles valuation to $157 billion in latest funding round, Tesla deliveries rose but analysts wanted more, and ...
Insider Monkey4d
Jim Cramer is Talking About These 12 Stocks
Cramer remains steadfast on Eli Lilly and Company (NYSE:LLY) as per Mad ... Mounjaro/Zepbound not only offers superb blood sugar control for diabetics but can drive 20%-plus weight loss and ...
When Ozempic goes WRONG! Celebrity slimming disasters that prove weight loss jab isn't always the 'miracle' it's cracked up to be...
The blockbuster weight loss drug thought to be behind countless celeb transformations doesn't work for everyone. The latest ...
The Hill on MSN6d
Competition explodes amid weight loss drug shortage
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...
Bank of England Gov Bailey jumps aboard the Fed's dove train – EU automakers extend slump
Notes/observations - Sterling dives >1% as BOE Gov Bailey sees chance of more aggressive rate cuts: UK Guardian newspaper ...